We just received data on a new analyst forecast for $ABBV. Citigroup gave a rating of 'Neutral' for $ABBV.
$ABBV Analyst Ratings
Wall Street analysts have issued reports on $ABBV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 02/03/2025
- Guggenheim issued a "Buy" rating on 02/03/2025
- Leerink Partners issued a "Outperform" rating on 11/22/2024
To track analyst ratings and price targets for $ABBV, check out Quiver Quantitative's $ABBV forecast page.
$ABBV Price Targets
Multiple analysts have issued price targets for $ABBV recently. We have seen 2 analysts offer price targets for $ABBV in the last 6 months, with a median target of $217.5.
Here are some recent targets:
- Gary Nachman from Raymond James set a target price of $220.0 on 02/03/2025
- Evan Seigerman from BMO Capital set a target price of $215.0 on 02/03/2025
$ABBV Congressional Stock Trading
Members of Congress have traded $ABBV stock 12 times in the past 6 months. Of those trades, 9 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/05, 03/17, 11/20 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $100,000 on 02/24 and 1 sale worth up to $100,000 on 04/17.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 3 purchases worth up to $45,000 on 04/07, 01/15 and 0 sales.
- REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 04/03.
- REPRESENTATIVE VIRGINIA FOXX purchased up to $15,000 on 12/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ABBV Insider Trading Activity
$ABBV insiders have traded $ABBV stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- TIMOTHY J. RICHMOND (EVP, CHIEF HR OFFICER) has made 0 purchases and 6 sales selling 29,917 shares for an estimated $6,070,036.
- KEVIN K BUCKBEE (SVP, CONTROLLER) has made 0 purchases and 3 sales selling 20,744 shares for an estimated $4,163,404.
- SCOTT T REENTS (EVP, CHIEF FINANCIAL OFFICER) sold 17,644 shares for an estimated $3,746,526
- PERRY C SIATIS (EVP, GC AND SECRETARY) has made 0 purchases and 2 sales selling 5,778 shares for an estimated $1,143,452.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABBV Hedge Fund Activity
We have seen 1,667 institutional investors add shares of $ABBV stock to their portfolio, and 1,729 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 7,996,758 shares (-28.0%) from their portfolio in Q1 2025, for an estimated $1,675,480,736
- JANUS HENDERSON GROUP PLC removed 5,800,981 shares (-57.7%) from their portfolio in Q4 2024, for an estimated $1,030,834,323
- FMR LLC added 5,539,207 shares (+30.6%) to their portfolio in Q1 2025, for an estimated $1,160,574,650
- BANK OF AMERICA CORP /DE/ added 4,383,302 shares (+20.9%) to their portfolio in Q4 2024, for an estimated $778,912,765
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 4,142,655 shares (-75.1%) from their portfolio in Q4 2024, for an estimated $736,149,793
- BLACKROCK, INC. added 3,842,577 shares (+2.7%) to their portfolio in Q1 2025, for an estimated $805,096,733
- LEGAL & GENERAL GROUP PLC removed 3,594,611 shares (-23.7%) from their portfolio in Q4 2024, for an estimated $638,762,374
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
